<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease causes a continuous T-lymphocytic mediated inflammatory reaction in the small arterioles, which results in gradual destruction of any human organ or system </plain></SENT>
<SENT sid="1" pm="."><plain>The benefit of treatment with <z:chebi fb="0" ids="23359">colchicine</z:chebi> in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease has been reported in literature </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002488'>Acute leukemia</z:hpo> has seldom been associated with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, although <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> is a particular subtype of <z:hpo ids='HP_0001909'>leukemia</z:hpo> that is often characterized by special cytogenetic abnormalities </plain></SENT>
<SENT sid="3" pm="."><plain>We report a male patient with <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease who had received long-term treatment with <z:chebi fb="0" ids="23359">colchicine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>To our knowledge, this is the first report of the concomitant occurrence of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, which suggests that long-term <z:chebi fb="0" ids="23359">colchicine</z:chebi> therapy has a role in the pathogenesis of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The patient described has been treated with <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> and <z:chebi fb="0" ids="42068">idarubicin</z:chebi> (the ATRA-IDA protocol) </plain></SENT>
<SENT sid="6" pm="."><plain>At the time of this writing, his disease is in clinical remission </plain></SENT>
</text></document>